Taiwan makes contingency plans for local oseltamivir production
This article was originally published in Scrip
Executive Summary
Taiwan has ordered new supplies of a raw material used in the production of oseltamivir, suggesting that it might again threaten to invoke compulsory licensing to secure sufficient supplies of the antiviral in case of any flu pandemic.